NASDAQ: BMRA - Biomerica, Inc.

Rentabilité sur six mois: -57.62%
Secteur: Healthcare

Calendrier des promotions Biomerica, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Plus de détails
It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Выручка 0.0052
EBITDA -0.0022
Число акций ао 0.01415 млрд
P/S 4.3
P/BV 5.62
EV/EBITDA -9.84
Цена ао 0.89
ISIN US09061H3075
Сайт https://www.biomerica.com
Валюта usd
IPO date 2005-01-03
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Changement de prix par jour: +6% (0.33)
Changement de prix par semaine: +11.05% (0.315)
Changement de prix par mois: -9.87% (0.3881)
Changement de prix sur 3 mois: -20.75% (0.4414)
Changement de prix sur six mois: -57.62% (0.8254)
Changement de prix par an: -53.97% (0.76)
Evolution du prix sur 3 ans: -93.18% (5.13)
Evolution du prix sur 5 ans: -87.6% (2.82)
Evolution des prix depuis le début de l'année: -63.18% (0.95)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 4.08 4
P/BV 1.86 8
P/E 0 0
EV/EBITDA -1.92 0
Total: 5.25

Efficacité

Nom Signification Grade
ROA, % -49.4 0
ROE, % -60.9 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.1575 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -19.18 0
Rentabilité Ebitda, % 215.42 10
Rentabilité EPS, % 54.44 7
Total: 6.2
Plus de détails

Établissements Volume Partager, %
Granahan Investment Management LLC 1082672 6.44
Wasatch Advisors LP 953264 5.67
Vanguard Group Inc 609365 3.62
Russell Investments Group, Ltd. 201563 1.2
Potomac Capital Management, Inc. 167700 1
Blackrock Inc. 149707 0.89
Geode Capital Management, LLC 120784 0.72
Susquehanna International Group, LLP 75916 0.45
CapTrust Financial Advisors 58668 0.35
Perritt Capital Management, Inc. 42500 0.25



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Gary Lu CPA Principal Accounting Officer & CFO 260k 1981 (43 année)
Ms. Lucy Liu Ph.D. Director of Manufacturing & Technical Operations N/A
Mr. Robert W. Carlson Chief Commercial Officer N/A
Mr. Zackary S. Irani CEO & Director 1966 (58 années)
Mr. Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary 1958 (66 années)

Adresse: United States, Irvine. CA, 17571 Von Karman Avenue - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.biomerica.com